Philip E. Thompson

99 Commercial Road
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 109 publications

Correction: Patient induced pluripotent stem cells identify specificities of a reticular pseudodrusen phenotype in age-related macular degeneration.

Correction: Patient induced pluripotent stem cells identify specificities of a reticular pseudodrusen phenotype in age-related macular degeneration.

Journal: Genome medicine

Published: July 22, 2026

Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors.

Goldilocks-Inspired Design of Mid-Size Macrocycles for Selective Targeting of Human Melanocortin Receptors.

Journal: Journal of medicinal chemistry

Published: June 24, 2026

Endosomal escape and cytosolic delivery of cell-penetrating peptide conjugates.

Endosomal escape and cytosolic delivery of cell-penetrating peptide conjugates.

Journal: Bioorganic & medicinal chemistry

Published: March 24, 2026

Diverse ring architectures of cyclic peptidomimetics targeting melanocortin receptors.

Diverse ring architectures of cyclic peptidomimetics targeting melanocortin receptors.

Journal: RSC medicinal chemistry

Published: February 12, 2026

Patient induced pluripotent stem cells identify specificities of a reticular pseudodrusen phenotype in age-related macular degeneration.

Patient induced pluripotent stem cells identify specificities of a reticular pseudodrusen phenotype in age-related macular degeneration.

Journal: Genome medicine

Published: December 05, 2025

Correction to "Synthesis of a New Purine Analogue Class with Antifungal Activity and Improved Potency against Fungal IP3-4K".

Correction to "Synthesis of a New Purine Analogue Class with Antifungal Activity and Improved Potency against Fungal IP3-4K".

Journal: ACS infectious diseases

Published: December 03, 2025

Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity.

Discovery and Characterization of VPRBP/DCAF1 Kinase Inhibitor Analogs as Microtubular Destabilizing Agents with Potent Antimyeloma Activity.

Journal: Molecular cancer therapeutics

Published: April 01, 2025

Synthesis of a New Purine Analogue Class with Antifungal Activity and Improved Potency against Fungal IP3-4K.

Synthesis of a New Purine Analogue Class with Antifungal Activity and Improved Potency against Fungal IP3-4K.

Journal: ACS infectious diseases

Published: March 31, 2025

VHL-independent degradation of hepatitis B virus e antigen (HBeAg) by VHL-binding chimeric small molecules.

VHL-independent degradation of hepatitis B virus e antigen (HBeAg) by VHL-binding chimeric small molecules.

Journal: RSC medicinal chemistry

Published: February 06, 2025

Methods to accelerate PROTAC drug discovery.

Methods to accelerate PROTAC drug discovery.

Journal: The Biochemical journal

Published: December 24, 2024

Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus.

Targeted protein degraders of SARS-CoV-2 Mpro are more active than enzymatic inhibition alone with activity against nirmatrelvir resistant virus.

Journal: Communications medicine

Published: November 21, 2024

Defeating MYC with drug combinations or dual-targeting drugs.

Defeating MYC with drug combinations or dual-targeting drugs.

Journal: Trends in pharmacological sciences

Published: March 11, 2024

Showing 1-12 of 109

Last Updated: 09/26/2026